Tamarack Advisers, LP

Holdings History for Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX)

Symbol: PCRX on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Jun 2023		-0.31%	$0	0	-10,000	-100%	$21.45	Q2 2023
31 Mar 2023	0.31%	-2.8%	$408,100	10,000	-90,000	-90%	$40.81	Q1 2023
31 Dec 2022	2.8%	-2.7%	$3,861,000	100,000	-95,000	-49%	$38.61	Q4 2022
30 Sep 2022	6.1%	+0.63%	$10,372,000	195,000	+20,000	+11%	$53.19	Q3 2022
30 Jun 2022	5.9%	-1%	$10,203,000	175,000	-30,000	-15%	$58.30	Q2 2022
31 Mar 2022	7.5%	-1.3%	$15,646,000	205,000	-35,000	-15%	$76.32	Q1 2022
31 Dec 2021	6%	-3.4%	$14,441,000	240,000	-135,000	-36%	$60.17	Q4 2021
30 Sep 2021	6.7%	+0.27%	$21,000,000	375,000	+15,000	+4.2%	$56.00	Q3 2021
30 Jun 2021	6.3%	-3.3%	$21,845,000	360,000	-190,000	-35%	$60.68	Q2 2021
31 Mar 2021	8%	-2.7%	$38,550,000	550,000	-185,000	-25%	$70.09	Q1 2021
31 Dec 2020	9.3%	+1%	$43,593,000	735,000	+80,000	+12%	$59.31	Q4 2020
30 Sep 2020	12%	-0.85%	$39,379,000	655,000	-45,000	-6.4%	$60.12	Q3 2020
30 Jun 2020	11%	+2.3%	$36,729,000	700,000	+150,000	+27%	$52.47	Q2 2020
31 Mar 2020	7.1%	-0.94%	$18,442,000	550,000	-72,500	-12%	$33.53	Q1 2020
31 Dec 2019	6.4%	-1.6%	$27,813,000	622,500	-152,500	-20%	$44.68	Q4 2019
30 Sep 2019	7.7%	+1.5%	$29,504,000	775,000	+150,000	+24%	$38.07	Q3 2019
30 Jun 2019	8.2%	+4%	$27,044,000	625,000	+305,000	+95%	$43.27	Q2 2019
31 Mar 2019	4.8%	+4.8%	$12,179,000	320,000	+320,000	NEW	$38.06	Q1 2019
31 Dec 2018		-2.1%	$0	0	-150,000	-100%	$21.45	Q4 2018
30 Sep 2018	2.1%	-0.56%	$7,373,000	150,000	-40,000	-21%	$49.15	Q3 2018
30 Jun 2018	2.1%	+0.77%	$6,090,000	190,000	+71,298	+60%	$32.05	Q2 2018
31 Mar 2018	1.8%	-2.9%	$3,698,000	118,702	-196,298	-62%	$31.15	Q1 2018
31 Dec 2017	7.9%	+1.6%	$14,380,000	315,000	+65,000	+26%	$45.65	Q4 2017
30 Sep 2017	5.8%	+0.81%	$9,388,000	250,000	+35,000	+16%	$37.55	Q3 2017
30 Jun 2017	6%	-1.4%	$10,256,000	215,000	-50,000	-19%	$47.70	Q2 2017
31 Mar 2017	7.6%	-0.23%	$12,084,000	265,000	-8,000	-2.9%	$45.60	Q1 2017
31 Dec 2016	6.3%	-2.9%	$8,818,000	273,000	-127,000	-32%	$32.30	Q4 2016
30 Sep 2016	4.5%	+2.4%	$14,164,000	400,000	+210,000	+111%	$35.41	Q3 2016
30 Jun 2016	2.5%	+2.5%	$6,409,000	190,000	+190,000	NEW	$33.73	Q2 2016

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.